Molbio Diagnostics IPO

Molbio Diagnostics Sets IPO Price Band At ₹768-807; Issue Opens On August 10

Behari Lal Engineering Sets ₹271-285 IPO Price Band For ₹302 Crore Issue, Subscription Opens August 12

Can Molbio Diagnostics IPO deliver long-term growth for high risk investors?

ET Intelligence Group: Molbio Diagnostics, a molecular diagnostics manufacturer, plans to raise ₹200 crore through a fresh issue for capital expenditure. It will also raise ₹740 crore through an offer for sale. The promoter group's stake will fall to 43% after the IPO from 46.6%. The company operates six manufacturing facilities across India and serves customers in over 90 countries, including government health programmes, diagnostic laboratories, hospitals, and international healthcare organisations. Its top clients contribute over half of the revenue, signalling customer concentration. Given

Molbio Diagnostics IPO Subscription Reaches 1.22 Times, Employee Portion Leads Demand On Day 2